07:49 AM EDT, 05/09/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported Q1 earnings Thursday of $ 2.27 per diluted share, down from $2.78 a year earlier.

Analysts polled by Capital IQ expected $2.06.

Revenue for the quarter ended March 30 was $1.01 billion, down from $1.03 billion a year earlier.

Analysts surveyed by Capital IQ expected $993.5 million.

The company reaffirmed expectations for full-year 2024 earnings of $10.90 to $11.40 per share. Analysts surveyed by Capital IQ expect $11.02.

Price: 238.00, Change: +2.71, Percent Change: +1.15